# NATCO Pharma Limited – FDA Inspection, Oct 18, 2023

Source: https://www.keypedia.com/records/fda_inspections/natco-pharma-limited/490eaf04-f2ac-48ef-96c9-2879ca06696c
Source feed: FDA_Inspections

> FDA inspection 1220533 of NATCO Pharma Limited, October 18, 2023. 8 citations under 21 CFR part 211. Form 483 issued. 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1220533
- Company Name: NATCO Pharma Limited
- Inspection Date: 2023-10-18
- Project Area: Drug Quality Assurance
- Center: Human Drugs
- Office Name: Office of Inspections and Investigations
- Citation Count: 8

## Related Documents

- [FDA Inspection 1273711 - 2025-06-19](https://www.keypedia.com/records/fda_inspections/natco-pharma-limited/80aae95c-db8b-4043-b5c3-41597f602f4d)
- FDA Inspection 1137171 - 2019-06-24
- [FDA Inspection 1095772 - 2019-06-06](https://www.keypedia.com/records/fda_inspections/natco-pharma-limited/ea855f48-56a5-4020-95b4-2e58b1a8caf2)
- [FDA Inspection 1011854 - 2017-01-24](https://www.keypedia.com/records/fda_inspections/natco-pharma-limited/6e9d6dc9-1872-4792-aa61-4d0ea396c351)
- FDA Inspection 880454 - 2014-05-23

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/pratik-s-upadhyay/22ff2e0b-17d4-4c91-a3f0-c7e30b7a115b)
- [Saleem A. Akhtar](https://www.keypedia.com/people/saleem-a-akhtar/1ea49212-bea5-4d43-bd0a-cdede4d3b1cf)

Company: https://www.keypedia.com/companies/natco-pharma-limited/4c97e2d8-0023-4572-966f-d396e8fecc05

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8
